Capital International Investors Cytokinetics Inc Transaction History
Capital International Investors
- $511 Billion
- Q4 2024
A detailed history of Capital International Investors transactions in Cytokinetics Inc stock. As of the latest transaction made, Capital International Investors holds 1,096,164 shares of CYTK stock, worth $50.9 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,096,164Holding current value
$50.9 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding CYTK
# of Institutions
396Shares Held
122MCall Options Held
3.46MPut Options Held
1.86M-
Black Rock Inc. New York, NY14.7MShares$681 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$553 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.8MShares$499 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA7.89MShares$366 Million0.07% of portfolio
-
State Street Corp Boston, MA6.17MShares$286 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.37B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...